Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.5230
+0.0031 (0.60%)
At close: Dec 5, 2025
Elite Pharmaceuticals Revenue
Elite Pharmaceuticals had revenue of $36.32M in the quarter ending September 30, 2025, with 92.38% growth. This brings the company's revenue in the last twelve months to $122.89M, up 72.67% year-over-year. In the fiscal year ending March 31, 2025, Elite Pharmaceuticals had annual revenue of $84.04M with 48.42% growth.
Revenue (ttm)
122.89M
Revenue Growth
+72.67%
P/S Ratio
4.55
Revenue / Employee
1.81M
Employees
68
Market Cap
558.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 84.04M | 27.42M | 48.42% |
| Mar 31, 2024 | 56.63M | 22.47M | 65.79% |
| Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
| Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
| Mar 31, 2021 | 25.38M | 7.39M | 41.05% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |
| Nuo Therapeutics | 2.61M |
Elite Pharmaceuticals News
- 16 days ago - ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance - Nasdaq
- 17 days ago - Elite Pharmaceuticals Inc (ELTP) Q2 2026 Earnings Call Highlights: Surging Revenues and ... - GuruFocus
- 18 days ago - Q2 2026 Elite Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 18 days ago - Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information - Newsfile Corp
- 25 days ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 - Newsfile Corp
- 3 months ago - Elite Pharmaceuticals Inc (ELTP) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ... - GuruFocus
- 4 months ago - Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M - Seeking Alpha